US Patent 8034594 Variant form of urate oxidase and use thereof
Patent 8034594 was granted and assigned to Savient Pharmaceuticals, Inc. on October, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 15 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+290 characters)
Article
Patent abstract
The present invention relates to genetically modified proteins with uricolytic activity. More specifically, the invention relates to proteins comprising truncated urate oxidases and methods for producing them, including PEGylated proteins comprising truncated urate oxidases.
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Jacob Hartman0
Simona Mendelovitz0
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08034594 Variant form of urate oxidase and use thereof US Patent 8034594 Variant form of urate oxidase and use thereof
Infobox
Patent Number
080345940
Patent Number
80345940
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080345940
Date of Patent
October 11, 2011
0Patent Application Number
131074980
Date Filed
May 13, 2011
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08034594 Variant form of urate oxidase and use thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08034594
Date of patent
October 11, 2011
Patent application number
13107498
Date Filed
May 13, 2011
Patent primary examiner
Find more entities like US Patent 8034594 Variant form of urate oxidase and use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.